At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of Urox™(Crateva, Horsetail and Lindera Combination) in the Treatment of Overactive Bladder and Urinary Incontinence
In Brief
A clinical study evaluating Urox and Placebo for Overactive Bladder and 3 related conditions. Completed, enrolled 150 participants.
Detailed Summary
This study aims to assess the efficacy of a specialized herbal formula, Urox, versus control over 8 weeks, in a double blind, placebo controlled trial. 150 participants are being recruited, randomized and administered treatment or placebo for the period of 8 weeks after initial eligibility screening. Outcome measures include previously validated tools such as the 3 day symptom diary measuring self-recorded day frequency, nocturia, urgency and incontinence episodes. Quality of life improvements are being measured using the Incontinence Impact Questionnaire, Urinary Distress Inventory and the short version of the OverActive Bladder survey.
Study Details
Timeline
Interventions
Active treatment - Proprietary combination of Crateva nurvala, Equisetum arvense and Lindera aggregata herbs
Placebo - Identical vegetarian capsule containing color-matched cellulose to that of the active treatment